Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (SHA:688505)

China flag China · Delayed Price · Currency is CNY
7.84
-0.20 (-2.49%)
Apr 17, 2026, 11:29 AM CST
Market Cap6.53B -0.4%
Revenue (ttm)685.80M -3.3%
Net Income-157.44M
EPS-0.15
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividend0.03 (0.37%)
Ex-Dividend DateJul 18, 2025
Volume2,907,177
Average Volume4,786,463
Open8.00
Previous Close8.04
Day's Range7.83 - 8.02
52-Week Range7.29 - 11.69
Beta0.19
RSI45.57
Earnings DateMar 30, 2026

About SHA:688505

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China. It offers genetic engineering platform drugs, including Trop2-SN38 ADC that is in Phase III clinical trials for Triple-negative breast cancer; CD30-DM1 antibody-drug conjugate (ADC), which have complected Phase I clinical trials for tumors; Trop2-BB05 ADC that is in Phase I clinical trial for tumors; DLL3-BB05 ADC, which is in phase I clinical trial for tumors; and H... [Read more]

Sector Healthcare
Founded 1996
Employees 923
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688505

Financial Performance

Financial Statements